NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL DN
| 634 | 384 | All SZGR 2.0 genes in this pathway |
KIM RESPONSE TO TSA AND DECITABINE UP
| 129 | 73 | All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA DN
| 349 | 157 | All SZGR 2.0 genes in this pathway |
IGARASHI ATF4 TARGETS DN
| 90 | 65 | All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 DN
| 175 | 82 | All SZGR 2.0 genes in this pathway |
TURASHVILI BREAST CARCINOMA DUCTAL VS LOBULAR UP
| 21 | 14 | All SZGR 2.0 genes in this pathway |
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
| 177 | 110 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL UP
| 450 | 256 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL UP
| 121 | 45 | All SZGR 2.0 genes in this pathway |
DOANE RESPONSE TO ANDROGEN UP
| 184 | 125 | All SZGR 2.0 genes in this pathway |
ROY WOUND BLOOD VESSEL DN
| 22 | 14 | All SZGR 2.0 genes in this pathway |
GAL LEUKEMIC STEM CELL DN
| 244 | 153 | All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER ADVANCED VS EARLY DN
| 138 | 70 | All SZGR 2.0 genes in this pathway |
JAEGER METASTASIS DN
| 258 | 141 | All SZGR 2.0 genes in this pathway |
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
| 275 | 168 | All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
| 205 | 127 | All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
| 142 | 90 | All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
| 143 | 83 | All SZGR 2.0 genes in this pathway |
TIEN INTESTINE PROBIOTICS 24HR DN
| 214 | 133 | All SZGR 2.0 genes in this pathway |
SABATES COLORECTAL ADENOMA UP
| 141 | 75 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA UP
| 1821 | 933 | All SZGR 2.0 genes in this pathway |
HAHTOLA SEZARY SYNDROM UP
| 98 | 58 | All SZGR 2.0 genes in this pathway |
HAHTOLA MYCOSIS FUNGOIDES UP
| 19 | 15 | All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE EPIDERMIS UP
| 293 | 179 | All SZGR 2.0 genes in this pathway |
MISSIAGLIA REGULATED BY METHYLATION UP
| 126 | 78 | All SZGR 2.0 genes in this pathway |
WANG BARRETTS ESOPHAGUS UP
| 51 | 27 | All SZGR 2.0 genes in this pathway |
MUELLER METHYLATED IN GLIOBLASTOMA
| 40 | 22 | All SZGR 2.0 genes in this pathway |
LI AMPLIFIED IN LUNG CANCER
| 178 | 108 | All SZGR 2.0 genes in this pathway |
PATIL LIVER CANCER
| 747 | 453 | All SZGR 2.0 genes in this pathway |
KANG GIST WITH PDGFRA DN
| 5 | 5 | All SZGR 2.0 genes in this pathway |
TSUNODA CISPLATIN RESISTANCE DN
| 51 | 38 | All SZGR 2.0 genes in this pathway |
WOOD EBV EBNA1 TARGETS DN
| 47 | 33 | All SZGR 2.0 genes in this pathway |
MOHANKUMAR TLX1 TARGETS DN
| 193 | 112 | All SZGR 2.0 genes in this pathway |
WANG HCP PROSTATE CANCER
| 111 | 69 | All SZGR 2.0 genes in this pathway |
GRUETZMANN PANCREATIC CANCER UP
| 358 | 245 | All SZGR 2.0 genes in this pathway |
NUYTTEN NIPP1 TARGETS DN
| 848 | 527 | All SZGR 2.0 genes in this pathway |
WU CELL MIGRATION
| 184 | 114 | All SZGR 2.0 genes in this pathway |
AMIT SERUM RESPONSE 480 MCF10A
| 39 | 20 | All SZGR 2.0 genes in this pathway |
LIN SILENCED BY TUMOR MICROENVIRONMENT
| 108 | 73 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 2 DN
| 464 | 276 | All SZGR 2.0 genes in this pathway |
TARTE PLASMA CELL VS PLASMABLAST UP
| 398 | 262 | All SZGR 2.0 genes in this pathway |
NAKAJIMA EOSINOPHIL
| 30 | 20 | All SZGR 2.0 genes in this pathway |
LEI MYB TARGETS
| 318 | 215 | All SZGR 2.0 genes in this pathway |
RADMACHER AML PROGNOSIS
| 78 | 52 | All SZGR 2.0 genes in this pathway |
VERHAAK AML WITH NPM1 MUTATED DN
| 246 | 180 | All SZGR 2.0 genes in this pathway |
KANG FLUOROURACIL RESISTANCE DN
| 16 | 10 | All SZGR 2.0 genes in this pathway |
GAJATE RESPONSE TO TRABECTEDIN UP
| 67 | 45 | All SZGR 2.0 genes in this pathway |
SATO SILENCED EPIGENETICALLY IN PANCREATIC CANCER
| 49 | 30 | All SZGR 2.0 genes in this pathway |
JOSEPH RESPONSE TO SODIUM BUTYRATE UP
| 31 | 21 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP
| 953 | 554 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
| 783 | 442 | All SZGR 2.0 genes in this pathway |
CREIGHTON ENDOCRINE THERAPY RESISTANCE 3
| 720 | 440 | All SZGR 2.0 genes in this pathway |
HELLER SILENCED BY METHYLATION UP
| 282 | 183 | All SZGR 2.0 genes in this pathway |
MASSARWEH TAMOXIFEN RESISTANCE UP
| 578 | 341 | All SZGR 2.0 genes in this pathway |
ENGELMANN CANCER PROGENITORS DN
| 70 | 44 | All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER RELAPSE IN PLEURA DN
| 27 | 15 | All SZGR 2.0 genes in this pathway |
HUPER BREAST BASAL VS LUMINAL UP
| 54 | 29 | All SZGR 2.0 genes in this pathway |
CROMER TUMORIGENESIS DN
| 51 | 29 | All SZGR 2.0 genes in this pathway |
PARK APL PATHOGENESIS DN
| 50 | 35 | All SZGR 2.0 genes in this pathway |
HAN SATB1 TARGETS UP
| 395 | 249 | All SZGR 2.0 genes in this pathway |
HAN SATB1 TARGETS DN
| 442 | 275 | All SZGR 2.0 genes in this pathway |
POOLA INVASIVE BREAST CANCER UP
| 288 | 168 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
| 170 | 105 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP
| 178 | 108 | All SZGR 2.0 genes in this pathway |
KOBAYASHI EGFR SIGNALING 24HR UP
| 101 | 65 | All SZGR 2.0 genes in this pathway |
HAHTOLA CTCL CUTANEOUS
| 26 | 19 | All SZGR 2.0 genes in this pathway |
HAHTOLA CTCL PATHOGENESIS
| 16 | 9 | All SZGR 2.0 genes in this pathway |
KYNG RESPONSE TO H2O2 VIA ERCC6 UP
| 40 | 30 | All SZGR 2.0 genes in this pathway |
HOFFMAN CLOCK TARGETS DN
| 10 | 6 | All SZGR 2.0 genes in this pathway |
DELPUECH FOXO3 TARGETS UP
| 68 | 49 | All SZGR 2.0 genes in this pathway |
GHANDHI DIRECT IRRADIATION DN
| 33 | 23 | All SZGR 2.0 genes in this pathway |
GHANDHI BYSTANDER IRRADIATION DN
| 12 | 10 | All SZGR 2.0 genes in this pathway |
NABA SECRETED FACTORS
| 344 | 197 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME ASSOCIATED
| 753 | 411 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME
| 1028 | 559 | All SZGR 2.0 genes in this pathway |